Pilot study of H2therapy in Parkinson's disease: A randomized double-blind placebo-controlled trial

MLA

Asako Yoritaka, et al. “Pilot Study of H2therapy in Parkinson’s Disease: A Randomized Double-Blind Placebo-Controlled Trial.” Movement Disorders, vol. 28, Feb. 2013, pp. 836–39. EBSCOhost, https://doi.org/10.1002/mds.25375.

APA

Asako Yoritaka, Toshiki Nakahara, Shigeo Ohta, Nobutaka Hattori, Masashi Takanashi, & Masaaki Hirayama. (2013). Pilot study of H2therapy in Parkinson’s disease: A randomized double-blind placebo-controlled trial. Movement Disorders, 28, 836–839. https://doi.org/10.1002/mds.25375

Chicago

Asako Yoritaka, Toshiki Nakahara, Shigeo Ohta, Nobutaka Hattori, Masashi Takanashi, and Masaaki Hirayama. 2013. “Pilot Study of H2therapy in Parkinson’s Disease: A Randomized Double-Blind Placebo-Controlled Trial.” Movement Disorders 28 (February): 836–39. doi:10.1002/mds.25375.